- In December 2023, Danaher Corporation acquired Abcam plc, a leader in protein consumables. Abcam will operate independently within Danaher’s Life Sciences division, which includes laser capture microdissection devices. This acquisition aligns with Danaher’s strategy to leverage advanced technology for better understanding complex diseases and accelerating drug discovery processes
- In November 2023, Laxco launched the Accuva Cellect Laser Capture Microdissection (LCM) system, designed for precise cell isolation and capture at individual levels. This innovation enhances research analysis with unparalleled accuracy, making it a pivotal tool for advancing studies in translational and clinical pathology
- In August 2023, Danaher Corporation (U.S.) acquired Abcam plc (U.K.), a leading provider of protein consumables. Abcam will maintain its independent operations under Danaher’s Life Sciences segment, supporting advancements in mapping complex diseases and expediting drug discovery through its cutting-edge technologies
- In March 2023, Crown Bioscience International (U.S.), part of JSR Life Sciences, acquired Indivumed Services GmbH & Co. KG (Germany). This acquisition integrates complementary platforms into Crown Bioscience's portfolio, boosting drug discovery efforts, addressing diverse customer needs, and accelerating the development of innovative therapeutic solutions
- In March 2020, Fluidigm Corporation introduced the AccuLift Laser Capture Microdissection System, enhancing translational and clinical pathology research. The system facilitates precise and efficient cell or tissue region capture for DNA, RNA, and protein biomarker analysis, driving advancements in molecular and cellular studies
